期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
A Convenient Fluorescent-labeled Assay for in vitro Measurement of DNA Mismatch Repair Activity 被引量:1
1
作者 SHI-YING LI XIANG-YU ZHANG +2 位作者 XIN ZHANG YAN LAN ZI-CHUN HUA 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2010年第6期496-501,共6页
Objective The assay of DNA mismatch repair (MMR) activity can be used as a biomarker for environmental condition detection and human disease diagnosis. Radioactive 32p-endlabeled DNA containing mismatch is extensive... Objective The assay of DNA mismatch repair (MMR) activity can be used as a biomarker for environmental condition detection and human disease diagnosis. Radioactive 32p-endlabeled DNA containing mismatch is extensively used as the substrate for MMR activity analyses. The aim of the present study is to develop a simple non-radioactive, but equally specific and sensitive method for the MMR activity assay. Methods A fluorescent label was chosen to replace the radioactive isotope label. Sensitive evaluation of the fluorescent label was carried out for the first time, and then the fluorescent label was compared with the isotope label in the MMR activity and DNA binding assays. Result LOD (limit of detection) of the fluorescent label was about 0.1 fmol and the relative signal strength displayed a pretty good linear relationship. Moreover, the fluorescent label method has equivalent sensitivity and performance as compared with the classical radioactive method in experiments. Conclusion In light of the sensitivity, reproducibility, safety, rapidity and long lifespan of the fluorescent label, this improved method can be applied to evaluation of biologic and toxic effects of environmental pollutants on man and other forms of life. 展开更多
关键词 Fluorescent label MMR activity EMSA TDG
下载PDF
Atorvastatin activates autophagy and promotes neurological function recovery after spinal cord injury 被引量:9
2
作者 Shuang Gao Zhong-ming Zhang +6 位作者 Zhao-liang Shen Kai Gao Liang Chang Yue Guo Zhuo Li Wei Wang Ai-mei Wang 《Neural Regeneration Research》 SCIE CAS CSCD 2016年第6期977-982,共6页
Atorvastatin, a lipid-lowering medication, provides neuroprotective effects, although the precise mechanisms of action remain unclear. Our previous studies confirmed activated autophagy following spinal cord injury, w... Atorvastatin, a lipid-lowering medication, provides neuroprotective effects, although the precise mechanisms of action remain unclear. Our previous studies confirmed activated autophagy following spinal cord injury, which was conducive to recovery of neurological functions. We hypothesized that atorvastatin could also activate autophagy after spinal cord injury, and subsequently improve recovery of neurological functions. A rat model of spinal cord injury was established based on the Allen method. Atorvastatin(5 mg/kg) was intraperitoneally injected at 1 and 2 days after spinal cord injury. At 7 days post-injury, western blot assay, reverse transcription-polymerase chain reaction, and terminal deoxynucleotidyl transferase-mediated dU TP nick-end labeling(TUNEL) staining results showed increased Beclin-1 and light chain 3B gene and protein expressions in the spinal cord injury + atorvastatin group. Additionally, caspase-9 and caspase-3 expression was decreased, and the number of TUNEL-positive cells was reduced. Compared with the spinal cord injury + saline group, Basso, Beattie, and Bresnahan locomotor rating scale scores significantly increased in the spinal cord injury + atorvastatin group at 14–42 days post-injury. These findings suggest that atorvastatin activated autophagy after spinal cord injury, inhibited apoptosis, and promoted recovery of neurological function. 展开更多
关键词 neurological autophagy caspase saline inhibited medication injected activate dehydrogenase labeling
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部